Emelie Styring

Lund, M, Sweden

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications

Low overall survival after treatment for angiosarcoma: a single-centre retrospective observational cohort study of 64 patients.

Low overall survival after treatment for angiosarcoma: a single-centre retrospective observational cohort study of 64 patients.

Journal: BMC cancer
Published: March 05, 2025

CDK4 is co-amplified with either TP53 promoter gene fusions or MDM2 through distinct mechanisms in osteosarcoma.

CDK4 is co-amplified with either TP53 promoter gene fusions or MDM2 through distinct mechanisms in osteosarcoma.

Journal: NPJ genomic medicine
Published: March 22, 2024

Osteosarcomas With Few Chromosomal Alterations or Adult Onset Are Genetically Heterogeneous.

Osteosarcomas With Few Chromosomal Alterations or Adult Onset Are Genetically Heterogeneous.

Journal: Laboratory investigation; a journal of technical methods and pathology
Published: June 22, 2023

Disruption of the TP53 locus in osteosarcoma leads to TP53 promoter gene fusions and restoration of parts of the TP53 signalling pathway.

Disruption of the TP53 locus in osteosarcoma leads to TP53 promoter gene fusions and restoration of parts of the TP53 signalling pathway.

Journal: The Journal of pathology
Published: April 24, 2023

Intralesional margin after excision of a high-grade osteosarcoma: Is it a catastrophe?

Intralesional margin after excision of a high-grade osteosarcoma: Is it a catastrophe?

Journal: Journal of surgical oncology
Published: March 03, 2022

Bone mineral: A trojan horse for bone cancers. Efficient mitochondria targeted delivery and tumor eradication with nano hydroxyapatite containing doxorubicin.

Bone mineral: A trojan horse for bone cancers. Efficient mitochondria targeted delivery and tumor eradication with nano hydroxyapatite containing doxorubicin.

Journal: Materials today. Bio
Published: December 18, 2021

Late Local Recurrence and Metastasis in Soft Tissue Sarcoma of the Extremities and Trunk Wall: Better Outcome After Treatment of Late Events Compared with Early.

Late Local Recurrence and Metastasis in Soft Tissue Sarcoma of the Extremities and Trunk Wall: Better Outcome After Treatment of Late Events Compared with Early.

Journal: Annals of surgical oncology
Published: June 05, 2020

Loss of NF2 defines a genetic subgroup of non-FOS-rearranged osteoblastoma.

Loss of NF2 defines a genetic subgroup of non-FOS-rearranged osteoblastoma.

Journal: The journal of pathology. Clinical research
Published: March 13, 2020

Respiratory failure and neurological impairment in a child with Duchenne muscular dystrophy following minor trauma

Respiratory failure and neurological impairment in a child with Duchenne muscular dystrophy following minor trauma

Journal: Lakartidningen
Published: June 26, 2019

High Recurrence Rate of Myxofibrosarcoma: The Effect of Radiotherapy Is Not Clear.

High Recurrence Rate of Myxofibrosarcoma: The Effect of Radiotherapy Is Not Clear.

Journal: Sarcoma
Published: April 17, 2019

Soft-tissue sarcoma in adolescents and young adults compared with older adults: A report among 5000 patients from the Scandinavian Sarcoma Group Central Register.

Soft-tissue sarcoma in adolescents and young adults compared with older adults: A report among 5000 patients from the Scandinavian Sarcoma Group Central Register.

Journal: Cancer
Published: March 31, 2019

Ewing sarcoma of the mobile spine; predictive factors for survival, neurological function and local control. A Scandinavian sarcoma group study with a mean follow-up of 12 years.

Ewing sarcoma of the mobile spine; predictive factors for survival, neurological function and local control. A Scandinavian sarcoma group study with a mean follow-up of 12 years.

Journal: Journal of bone oncology
Published: September 16, 2018
Showing 1-12 of 22

Last Updated: 09/26/2026